BioXcel Therapeutics
BTAI
BTAI
20 hedge funds and large institutions have $34.2M invested in BioXcel Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
29% less capital invested
Capital invested by funds: $47.9M → $34.2M (-$13.7M)
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$257K | |
| 2 | +$137K | |
| 3 | +$137K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$58.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53.3K |
Top Sellers
| 1 | -$6.33M | |
| 2 | -$2.05M | |
| 3 | -$922K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$428K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$275K |